Literature DB >> 28177945

Concerns about andexanet.

Claudia Stöllberger1, Birke Schneider.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28177945     DOI: 10.1097/MBC.0000000000000624

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


× No keyword cloud information.
  1 in total

Review 1.  Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy.

Authors:  Michelangelo Sartori; Benilde Cosmi
Journal:  J Thromb Thrombolysis       Date:  2018-04       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.